AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,321,000 | +93.0% | 96,400 | -6.4% | 0.00% | +50.0% |
| Q2 2020 | $1,721,000 | +19.3% | 102,963 | +3.0% | 0.00% | 0.0% |
| Q1 2020 | $1,442,000 | -57.3% | 100,003 | -0.8% | 0.00% | -33.3% |
| Q4 2019 | $3,374,000 | +95.8% | 100,803 | +22.5% | 0.00% | +50.0% |
| Q3 2019 | $1,723,000 | +62.4% | 82,303 | +61.6% | 0.00% | +100.0% |
| Q2 2019 | $1,061,000 | -5.9% | 50,941 | +1.0% | 0.00% | 0.0% |
| Q1 2019 | $1,127,000 | -8.7% | 50,441 | -2.3% | 0.00% | -50.0% |
| Q4 2018 | $1,235,000 | -18.9% | 51,641 | -7.5% | 0.00% | 0.0% |
| Q3 2018 | $1,523,000 | -3.1% | 55,841 | -4.5% | 0.00% | 0.0% |
| Q2 2018 | $1,572,000 | +27.0% | 58,455 | +50.3% | 0.00% | 0.0% |
| Q1 2018 | $1,238,000 | – | 38,895 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,100,146 | $117,248,000 | 40.96% |
| TLP GROUP LLC | 1,050,000 | $39,711,000 | 27.53% |
| Aisling Capital LLC | 2,240,000 | $84,717,000 | 16.74% |
| Foresite Capital Management III, LLC | 764,824 | $28,926,000 | 8.12% |
| AlpInvest Partners B.V. | 51,498 | $1,948,000 | 6.95% |
| Vivo Capital, LLC | 643,626 | $24,342,000 | 5.21% |
| GREAT POINT PARTNERS LLC | 573,550 | $21,692,000 | 3.70% |
| Eventide Asset Management | 1,226,000 | $46,367,000 | 2.42% |
| Palo Alto Investors LP | 1,146,419 | $43,358,000 | 1.87% |
| HAMILTON LANE ADVISORS LLC | 78,846 | $2,982,000 | 1.54% |